TriSalus Life Sciences, Inc.
TLSI
$5.10
$0.173.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.29M | -10.38M | -10.11M | -2.39M | -4.33M |
| Total Depreciation and Amortization | 165.00K | 172.00K | 193.00K | 169.00K | 194.00K |
| Total Amortization of Deferred Charges | 257.00K | 235.00K | 178.00K | 167.00K | 267.00K |
| Total Other Non-Cash Items | 1.93M | 3.87M | 3.56M | -5.64M | -3.17M |
| Change in Net Operating Assets | -1.39M | 1.60M | 467.00K | -3.15M | -6.38M |
| Cash from Operations | -7.32M | -4.50M | -5.71M | -10.85M | -13.42M |
| Capital Expenditure | 93.00K | -754.00K | -50.00K | -169.00K | -60.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 40.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.00K | -714.00K | -50.00K | -169.00K | -60.00K |
| Total Debt Issued | 0.00 | 10.00M | 0.00 | 0.00 | 25.00M |
| Total Debt Repaid | -1.00K | -71.00K | -19.00K | -22.00K | -21.00K |
| Issuance of Common Stock | 22.27M | 279.00K | 3.01M | 5.85M | 3.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.55M | -520.00K | 0.00 | 0.00 | -2.59M |
| Cash from Financing | 20.72M | 9.69M | 2.99M | 5.82M | 25.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.49M | 4.48M | -2.76M | -5.19M | 12.51M |